TWiV 713: COVID-19 clinical update #47 with Dr. Daniel Griffin
- January 30, 2021
- Tagged as: colchicine, coronavirus, COVID-19, monoclonal antibody, pandemic, SARS-CoV-2, Vaccine, viral, virology, virus, viruses
In COVID-19 clinical update #47, Daniel Griffin reviews phase 3 results for Novavax and J&J vaccines, transmission in K-12 settings in Wisconsin, data on Lilly and Regeneron monoclonal antibody therapy, and a study of colchicine for treatment of disease.
